TOP｜ 特許｜ 意匠｜ 商標
商標ウォッチ Twitter
公開日2024-11-13
公報種別公開国際商標公報
国際登録番号1809806
国際登録日2024-06-03
区分第5類(薬剤),第42類(科学・技術),第44類(医療・農林業)
商品役務Biological preparations for gene therapy; adeno-associated virus (aav) gene therapy preparations and pharmaceuticals; biological preparations for treatment of neurological diseases and disorders; gene therapy preparations for treatment of disease, namely, neurological diseases; medical preparations and pharmaceuticals for treatment of neurological diseases via gene replacement, gene knockdown, or vectorized antibodies; gene therapy preparations for neurological diseases; nucleic acids encoding polypeptides for gene therapy; drug delivery agents comprising compounds that facilitate delivery of a wide range of pharmaceuticals and biotherapeutics; drug delivery agents comprising capsids that facilitate delivery of a wide range of pharmaceuticals and biotherapeutics.,Pharmaceutical research and development in the field of gene therapy; pharmaceutical research and development for the treatment of neurological diseases and disorders; scientific research in the field of gene therapy; pharmaceutical research services; research and development of pharmaceutical preparations for gene therapy; research and development of pharmaceutical preparations for neurological diseases; biotechnology research services; research and development of platform technologies for genetic delivery of therapies and pharmaceuticals; research and development services in the field of platforms technologies for genetic delivery of therapies and pharmaceuticals; research and development in the pharmaceutical and biotechnology fields; research and development regarding the use of rna-derived functional screening platforms to discover, research and develop novel capsids for genetic deliver of therapies and pharmaceuticals; research and development regarding the identification and targeting of specific cells and tissues for gene therapy delivery.,Medical treatment of neurological diseases via gene replacement, gene knockdown, or vectorized antibodies, namely, Parkinson’s disease, Huntington’s disease, Friedreich’s ataxia, amyotrophic lateral sclerosis (ALS), Alzheimer’s disease, tauopathies, synucleinopathies, and neurodegenerative disease.
基礎出願番号90879826
基礎出願日2021-08-12
基礎出願国US
出願人Voyager Therapeutics, Inc.
OCRテキストVOYAGEK
OCRテキスト2VOYAGER
OCRについて
この商標をJ-PlatPatで参照する

関連商標

Bayer Consumer Care AG
BEPANTHEN
3か月前
Triticum Exploitatie B.V.
L-MESITRAN
7か月前
Novartis AG
OJUVIP
8か月前
JADRAN - GALENSKI LABORATORIJ d.d.
MERALYS
5か月前
ROXALL Medizin GmbH
SULGEN
2か月前
ROXALL Medizin GmbH
ROXALL
2か月前
個人
GI-MASK
10か月前
ROXALL Medizin GmbH
1か月前
BOLERO & Co Ltd.
BOLERO
7か月前
個人
SPEEDEX
6か月前
COSWELL S.p.A.
BLANX
10か月前
Orion Corporation
ORIONPHARMA
4か月前
個人
VISTA
11か月前
DePuy Ireland Unlimited Company
SMARTSET
1か月前
Ursapharm Arzneimittel GmbH
HYLO
5日前
Ursapharm Arzneimittel GmbH
HYLO
5日前
Opti Licences Pty Ltd
OptiSlim
9か月前
Annex Foods Brands Pty Ltd
REDTRACTOR
6か月前
Annex Foods Brands Pty Ltd
O
6か月前
PECTEN GROUP S.R.L.
FAP FERMENTEDAVOCADO PREPARATION
5か月前
VISIONMED LTD
StarFill
6か月前
Biohaven Therapeutics Ltd.
REJUTRIA
3か月前
個人
GET ONE
6か月前
SURAJ BAHIRWANI
GUMAZING
1か月前
TerraPower, LLC
tpi TERRAPOWER ISOTOPES
5か月前
PAUL HARTMANN AG
PREVENTIA
2か月前
PECTEN GROUP S.R.L.
DEAVOCADO
5か月前
NORDIC BIOTIC Sp. z o.o.
NORDBIOTIC
2か月前
Aspivix SA
ASPIVIX
2か月前
TerraPower, LLC
4か月前
INTERSALES COMPANY, naamloze vennootschap
FORNATURAL ENERGY MALT DRINK AND VITALITY
9か月前
NOVARTIS AG
1か月前
NOVARTIS AG
1か月前
NOVARTIS AG
CREYTIVBI
2か月前
NOVARTIS AG
1か月前
BRILL INTERNATIONAL, S.L.
3か月前
続きを見る